{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:44:03Z","timestamp":1792604643509,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd008550","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,11,24]],"date-time":"2014-11-24T00:00:00Z","timestamp":1416787200000}}],"reference-count":107,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008550.pub2","type":"journal-article","created":{"date-parts":[[2014,11,24]],"date-time":"2014-11-24T20:34:50Z","timestamp":1416861290000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Pharmacological treatment of children with gastro-oesophageal reflux"],"prefix":"10.1002","volume":"2016","author":[{"given":"Mark","family":"Tighe","sequence":"first","affiliation":[{"name":"Poole Hospital NHS Foundation Trust; Department of Paediatrics; Longfleet Road Poole Dorset UK BH15 2JB"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem A","family":"Afzal","sequence":"additional","affiliation":[{"name":"University Hospital Southampton NHS Foundation Trust; Child Health; Tremona Road Southampton Hampshire UK SO16 6YD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Bevan","sequence":"additional","affiliation":[{"name":"University Hospital Southampton NHS Foundation Trust; Department of Pharmacy; Tremona Road Southampton Hampshire UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Hayen","sequence":"additional","affiliation":[{"name":"University of Technology; Faculty of Health; Ultimo NSW Australia 2007"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alasdair","family":"Munro","sequence":"additional","affiliation":[{"name":"Poole Hospital NHS Foundation Trust; Department of Paediatrics; Longfleet Road Poole Dorset UK BH15 2JB"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R Mark","family":"Beattie","sequence":"additional","affiliation":[{"name":"University Hospital Southampton NHS Foundation Trust; Child Health; Tremona Road Southampton Hampshire UK SO16 6YD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,11,24]]},"reference":[{"issue":"9","key":"10.1002\/14651858.CD008550.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1177\/0009922810369253","article-title":"Clinical results from a randomised, double-blind, dose-ranging study of pantoprazole in children aged 1 through 5 years with symptomatic histologic or erosive esophagitis","volume":"49","author":"Baker","year":"2010","journal-title":"Clinical Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD008550.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/00005176-199205000-00005","article-title":"Efficacy of domperidone in infants and children with gastroesophageal reflux","volume":"14","author":"Bines","year":"1992","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"key":"10.1002\/14651858.CD008550.pub2-BIB0003|cit3","first-page":"304","article-title":"Efficacy of combined administration of an alginate formulation (Gaviscon) and lansoprazole for children with gastroesophageal reflux","volume":"28","author":"Borrelli","year":"2002","journal-title":"Italian Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD008550.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/BF02343223","article-title":"Double-blind controlled study on the efficacy of sodium alginate (Gaviscon) in reducing gastroesophageal reflux assessed by 24 h continuous pH monitoring in infants and children","volume":"146","author":"Buts","year":"1987","journal-title":"European Journal of Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD008550.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3109\/00365529409094839","article-title":"Domperidone plus magnesium hydroxide and aluminium hydroxide: a valid therapy in children with gastroesophageal reflux","volume":"29","author":"Carroccio","year":"1994","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD008550.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/jp.2008.81","article-title":"Short-term effect of domperidone on gastroesophageal reflux in newborns assessed by combined intraluminal impedance and pH monitoring","volume":"28","author":"Cresi","year":"2008","journal-title":"Journal of Perinatology"},{"key":"10.1002\/14651858.CD008550.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/adc.59.9.842","article-title":"Antacids and cimetidine treatment for gastrooesophageal reflux and peptic oesophagitis","volume":"59","author":"Cucchiara","year":"1984","journal-title":"Archives of Disease in Childhood"},{"key":"10.1002\/14651858.CD008550.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1136\/adc.69.6.655","article-title":"Omeprazole and high dose ranitidine in the treatment of refractory reflux oesophagitis","volume":"69","author":"Cucchiara","year":"1993","journal-title":"Archives of Disease in Childhood"},{"key":"10.1002\/14651858.CD008550.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1136\/adc.2002.024463","article-title":"Effect of Gaviscon Infant on gastro-oesophageal reflux in infants assessed by combined intraluminal impedance\/pH","volume":"90","author":"Buono","year":"2005","journal-title":"Archives of Disease in Childhood"},{"issue":"4","key":"10.1002\/14651858.CD008550.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/00005176-198607000-00008","article-title":"The effects of Gaviscon and metoclopramide in gastroesophageal reflux in children","volume":"5","author":"Forbes","year":"1986","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"4","key":"10.1002\/14651858.CD008550.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"S327","DOI":"10.1097\/00005176-200211004-00005","article-title":"Lansoprazole in adolescents with gastroesophageal reflux disease: pharmacokinetics, pharmacodynamics, symptom relief efficacy, and tolerability","volume":"35","author":"Gunasekaran","year":"2002","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"key":"10.1002\/14651858.CD008550.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10620-010-1321-3","article-title":"Pharmacodynamics and safety of pantoprazole in neonates, preterm infants, and infants aged 1-11 months with a clinical diagnosis of gastroesophageal reflux disease","volume":"56","author":"Kierkus","year":"2011","journal-title":"Digestive Diseases and Sciences"},{"issue":"3","key":"10.1002\/14651858.CD008550.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1185\/03007999909114087","article-title":"Comparison of the efficacy and safety of a new aluminum-free paediatric alginate preparation and placebo in infants with recurrent gastro-oesophageal reflux","volume":"15","author":"Miller","year":"1999","journal-title":"Current Medical Research and Opinion"},{"issue":"2","key":"10.1002\/14651858.CD008550.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1067\/S0022-3476(03)00207-5","article-title":"Double-blind placebo-controlled trial of omeprazole in irritable infants with gastroesophageal reflux","volume":"143","author":"Moore","year":"2003","journal-title":"Journal of Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD008550.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jpeds.2006.05.029","article-title":"Effect of baclofen on esophagogastric motility and gastroesophageal reflux in children with gastroesophageal reflux disease: a randomized controlled trial","volume":"149","author":"Omari","year":"2006","journal-title":"Journal of Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD008550.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/MPG.0b013e31812e012f","article-title":"Pharmacokinetics and acid-suppressive effects of esomeprazole in infants 1-24 months old with symptoms of gastroesophageal reflux disease","volume":"45","author":"Omari","year":"2007","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"9","key":"10.1002\/14651858.CD008550.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1046\/j.1365-2036.2003.01559.x","article-title":"Famotidine for infant gastro-oesophageal reflux: a multi-centre, randomized, placebo-controlled, withdrawal trial","volume":"17","author":"Orenstein","year":"2003","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD008550.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jpeds.2008.09.054","article-title":"Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease","volume":"154","author":"Orenstein","year":"2009","journal-title":"Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD008550.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/01.mpg.0000189354.48043.4e","article-title":"Nocturnal acid breakthrough in children with reflux esophagitis taking proton pump inhibitors","volume":"42","author":"Pfefferkorn","year":"2006","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"1","key":"10.1002\/14651858.CD008550.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00005176-199707000-00008","article-title":"Treatment of childhood peptic esophagitis: a double-blind placebo-controlled trial of nizatidine","volume":"25","author":"Simeone","year":"1997","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"4","key":"10.1002\/14651858.CD008550.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/01.mpg.0000214160.37574.d3","article-title":"Multicenter, randomized, double-blind study comparing 10, 20 and 40 mg pantoprazole in children (5-11 years) with symptomatic gastroesophageal reflux disease","volume":"42","author":"Tolia","year":"2006","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"5","key":"10.1002\/14651858.CD008550.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/MPG.0b013e3181ddcf11","article-title":"Healing of erosive esophagitis and improvement of symptoms of gastroesophageal reflux disease after esomeprazole treatment in children 12 to 36 months old","volume":"51","author":"Tolia","year":"2010","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"key":"10.1002\/14651858.CD008550.pub2-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1471-2431-10-41","article-title":"Esomeprazole for the treatment of erosive esophagitis in children: an international, multicenter, randomized, parallel-group, double-blind (for dose) study","volume":"10","author":"Tolia","year":"2010","journal-title":"BMC Pediatrics"},{"issue":"8","key":"10.1002\/14651858.CD008550.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1177\/0009922806292792","article-title":"Multicenter, randomized, double-blind study comparing 20 and 40 mg of pantoprazole for symptom relief in adolescents (12 to 16 years of age) with gastroesophageal reflux disease (GERD)","volume":"45","author":"Tsou","year":"2006","journal-title":"Clinical Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD008550.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"442-51","DOI":"10.1097\/00005176-200404000-00015","article-title":"Developmental pharmacokinetics and pharmacodynamics of nizatidine","volume":"38","author":"Abdel-Rahman","year":"2004","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"2","key":"10.1002\/14651858.CD008550.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0022-3476(98)70460-3","article-title":"Omeprazole in infants with cimetidine-resistant peptic esophagitis","volume":"132","author":"Alli\u00ebt","year":"1998","journal-title":"Journal of Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD008550.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2165\/00148581-200608040-00005","article-title":"Ranitidine (Zantac) syrup vs ranitidine effervescent tablets (Zantac EFFERdose) in children, a single-center taste preference study","volume":"8","author":"Ameen","year":"2006","journal-title":"Pediatric Drugs"},{"issue":"6","key":"10.1002\/14651858.CD008550.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0002-9343(89)90162-9","article-title":"Sucralfate versus cimetidine in the treatment of reflux esophagitis in children","volume":"86","author":"Arg\u00fcelles-Martin","year":"1989","journal-title":"The American Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD008550.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2165\/00148581-200406020-00005","article-title":"Medications that can be fatal for a toddler with one tablet or teaspoonful a 2004 update","volume":"6","author":"Bar-Oz","year":"2004","journal-title":"Pediatric Drugs"},{"key":"10.1002\/14651858.CD008550.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0009-9236(97)90170-3","article-title":"The triangular test to assess the efficacy of metoclopramide in gastroesophageal reflux","volume":"61","author":"Bellissant","year":"1997","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD008550.pub2-BIB0031|cit31","first-page":"203","article-title":"Chronic regurgitation and vomiting treated with domperidone; a multicentre evaluation","volume":"32","author":"Clara","year":"1979","journal-title":"Acta Paediatrica Belgica"},{"key":"10.1002\/14651858.CD008550.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0022-3476(99)70451-8","article-title":"Cisapride in the control of symptoms in infants with gastroesophageal reflux: a randomised, double-blind, placebo-controlled trial","volume":"134","author":"Cohn","year":"1999","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD008550.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2036.2010.04545.x","article-title":"The efficacy of sodium alginate (Gaviscon) for the treatment of gastro-oesophageal reflux in preterm infants","volume":"33","author":"Corvaglia","year":"2011","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"5","key":"10.1002\/14651858.CD008550.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/00005176-199705000-00007","article-title":"Omeprazole for severe reflux esophagitis in children","volume":"24","author":"Giacomo","year":"1997","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"key":"10.1002\/14651858.CD008550.pub2-BIB0035|cit35","first-page":"40","article-title":"Domperidone drops in the symptomatic treatment of chronic paediatric vomiting and regurgitation. A comparison with metoclopramide","volume":"55 Suppl 1","author":"Loore","year":"1979","journal-title":"Postgraduate Medical Journal"},{"key":"10.1002\/14651858.CD008550.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1651-2227.2004.tb00680.x","article-title":"Diagnosis and management of gastro-oesophageal reflux in preterm infants in neonatal intensive care units","volume":"93","author":"Dhillon","year":"2004","journal-title":"Acta Paediatrica"},{"issue":"3","key":"10.1002\/14651858.CD008550.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/01.MPG.0000155369.54464.41","article-title":"Efficacy and safety of lansoprazole in adolescents with symptomatic erosive and non-erosive gastro-oesophageal reflux disease","volume":"40","author":"Fiedorek","year":"2005","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"8","key":"10.1002\/14651858.CD008550.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S1590-8658(00)80326-6","article-title":"Lansoprazole in the treatment of gastro-oesophageal reflux disease in childhood","volume":"32","author":"Franco","year":"2000","journal-title":"Digestive and Liver Disease"},{"key":"10.1002\/14651858.CD008550.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/adc.67.5.618","article-title":"Gaviscon and carobel compared with cisapride in gastro-oesophageal reflux","volume":"67","author":"Greally","year":"1992","journal-title":"Archives of Disease in Childhood"},{"key":"10.1002\/14651858.CD008550.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0022-3476(85)80315-2","article-title":"Effects of domperidone therapy on symptoms and upper gastrointestinal motility in infants with gastrooesophageal reflux","volume":"106","author":"Grill","year":"1985","journal-title":"Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD008550.pub2-BIB0041|cit41","first-page":"332","article-title":"Efficacy and safety of omeprazole for severe gastroesophageal reflux in children","volume":"124","author":"Gunasekaran","year":"1994","journal-title":"Journal of Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD008550.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1067\/mpd.2000.109607","article-title":"Omeprazole for treatment of chronic erosive esophagitis in children: a multicenter study of efficacy, safety, tolerability and dose requirements","volume":"137","author":"Hassall","year":"2000","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD008550.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1365-2036.2011.04950.x","article-title":"Long-term maintenance treatment with omeprazole in children with healed erosive oesophagitis: a prospective study","volume":"35","author":"Hassall","year":"2012","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD008550.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/00005176-198609000-00008","article-title":"Effect of metoclopramide on prolonged intraesophageal pH testing in infants with gastroesophageal reflux","volume":"5","author":"Hyams","year":"1986","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"9","key":"10.1002\/14651858.CD008550.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.clinthera.2007.09.007","article-title":"Pharmacokinetics and tolerability of rabeprazole sodium in subjects aged 12 to 16 years with gastroesophageal reflux disease: an open-label, single- and multiple-dose study","volume":"29","author":"James","year":"2007","journal-title":"Clinical Therapeutics"},{"issue":"1-2","key":"10.1002\/14651858.CD008550.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1440-1754.2006.00786.x","article-title":"Effect of antireflux medication, placebo and infant mental health intervention on persistent crying: a randomized clinical trial","volume":"42","author":"Jordan","year":"2006","journal-title":"Journal of Paediatrics and Child Health"},{"key":"10.1002\/14651858.CD008550.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/archpedi.1995.02170150047007","article-title":"Omeprazole treatment of children with peptic esophagitis refractory to ranitidine therapy","volume":"149","author":"Karjoo","year":"1995","journal-title":"Archives of Pediatrics and Adolescent Medicine"},{"issue":"3","key":"10.1002\/14651858.CD008550.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0022-3476(96)70293-7","article-title":"Effect of omeprazole in the treatment of refractory acid-related diseases in childhood: endoscopic healing and 24 hour intragastric activity","volume":"128","author":"Kato","year":"1996","journal-title":"Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD008550.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1124\/jpet.110.167783","article-title":"E3710, a new proton pump inhibitor, with a long lasting inhibitory effect on gastric acid secretion","volume":"334","author":"Kodama","year":"2010","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD008550.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/MPG.0b013e31822a323a","article-title":"Pharmacokinetics and safety of dexlansoprazole MR in adolescents with symptomatic GERD","volume":"54","author":"Kukulka","year":"2012","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"11","key":"10.1002\/14651858.CD008550.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.clinthera.2006.11.012","article-title":"Pharmacokinetic properties of esomeprazole in children aged 1 to 11 years with symptoms of gastroesophageal reflux disease: a randomized, open-label study","volume":"28","author":"Li","year":"2006","journal-title":"Clinical Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD008550.pub2-BIB0052|cit52","first-page":"S68","article-title":"Esophageal impedance baselines in infants before and after placebo, antacid and proton pump inhibitor therapy","volume":"53","author":"Loots","year":"2011","journal-title":"5th European Motility Meeting: Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"2","key":"10.1002\/14651858.CD008550.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00005176-200302000-00019","article-title":"Efficacy and safety of oral pantoprazole 20 mg given once daily for reflux esophagitis in children","volume":"36","author":"Madrazo-de la Garza","year":"2003","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"key":"10.1002\/14651858.CD008550.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/BF00637754","article-title":"Use of ranitidine in young infants with gastro-oesophageal reflux","volume":"36","author":"Mallet","year":"1989","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD008550.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-2008-1066506","article-title":"The use of omeprazole for resistant oesophagitis in children","volume":"6","author":"Martin","year":"1996","journal-title":"European Journal of Pediatric Surgery"},{"issue":"4","key":"10.1002\/14651858.CD008550.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-2008-1066506","article-title":"The use of omeprazole for resistant oesophagitis in children","volume":"6","author":"Martin","year":"1996","journal-title":"European Journal of Pediatric Surgery"},{"key":"10.1002\/14651858.CD008550.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1542\/peds.102.6.e67","article-title":"One-year follow-up of symptoms of gastroesophageal reflux during infancy","volume":"102","author":"Nelson","year":"1998","journal-title":"Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD008550.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00005176-200410000-00015","article-title":"Severe gastroesophageal reflux disease and cow milk hypersensitivity in infants and children: disease association and evaluation of a new challenge procedure","volume":"39","author":"Nielsen","year":"2004","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"2","key":"10.1002\/14651858.CD008550.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jpeds.2009.02.025","article-title":"Pharmacodynamics and systemic exposure of esomeprazole in preterm infants and term neonates with gastroesophageal reflux disease","volume":"155","author":"Omari","year":"2009","journal-title":"Journal of Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD008550.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.clinthera.2005.04.008","article-title":"Nizatidine for the treatment of pediatric gastroesophageal reflux symptoms: an open-label, multiple-dose, randomized, multicenter clinical trial in 210 children","volume":"27","author":"Orenstein","year":"2005","journal-title":"Clinical Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD008550.pub2-BIB0061|cit61","first-page":"111","article-title":"Gastric acid suppression of a new oral powder omeprazole suspension for infants with gastroesophageal reflux disease. A pilot study","volume":"41","author":"Orsi","year":"2011","journal-title":"Acta Gastroenterologica Latinoamericana"},{"issue":"2","key":"10.1002\/14651858.CD008550.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/08035250500327609","article-title":"Oral ranitidine and duration of gastric pH <4.0 in infants with persisting reflux symptoms","volume":"95","author":"Salvatore","year":"2006","journal-title":"Acta Paediatrica"},{"issue":"9","key":"10.1002\/14651858.CD008550.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/adc.2004.068890","article-title":"Acid suppression does not change respiratory symptoms in children with asthma and gastro-oesophageal reflux disease","volume":"90","author":"St\u00f8rdal","year":"2005","journal-title":"Archives of Disease in Childhood"},{"issue":"8","key":"10.1002\/14651858.CD008550.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2165\/11591900-000000000-00000","article-title":"Randomized, open-label, multicentre pharmacokinetic studies of two dose levels of pantoprazole granules in infants and children aged 1 month through <6 years with gastro-oesophageal reflux disease","volume":"50","author":"Tammara","year":"2011","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1002\/14651858.CD008550.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1542\/peds.2011-0796","article-title":"Ranitidine is associated with infections, necrotizing enterocolitis, and fatal outcome in newborns","volume":"129","author":"Terrin","year":"2012","journal-title":"Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD008550.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-2036.2003.01446.x","article-title":"A randomized, double-blind trial of the efficacy and safety of 10 or 20 mg rabeprazole compared with 20 mg omeprazole in the maintenance of gastro-oesophageal reflux disease over 5 years","volume":"17","author":"Thjodleifsson","year":"2003","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD008550.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"S308","DOI":"10.1097\/00005176-200211004-00003","article-title":"Efficacy of lansoprazole in the treatment of gastrooesophageal reflux in children","volume":"35","author":"Tolia","year":"2002","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"5","key":"10.1002\/14651858.CD008550.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1067\/mcp.2002.122472","article-title":"Pharmacokinetic-pharmacodynamic study of oral lansoprazole in children","volume":"71","author":"Tran","year":"2002","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD008550.pub2-BIB0069|cit69","first-page":"S69","article-title":"Effect of lansoprazole plus domperidone for treatment of gastroesophageal reflux disease in infants","volume":"53","author":"Treepongkaruna","year":"2011","journal-title":"5th European Motility Meeting: Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"6","key":"10.1002\/14651858.CD008550.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1177\/0091270010377501","article-title":"A multicenter, randomized, open-label, pharmacokinetics and safety study of pantoprazole tablets in children and adolescents aged 6 through 16 years with gastroesophageal reflux disease","volume":"51","author":"Ward","year":"2011","journal-title":"Journal of Clinical Pharmacology"},{"issue":"6","key":"10.1002\/14651858.CD008550.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/MPG.0b013e3181c2bf41","article-title":"Efficacy and safety of pantoprazole delayed-release granules for oral suspension in a placebo-controlled treatment-withdrawal study in infants 1-11 months old with symptomatic GERD","volume":"50","author":"Winter","year":"2010","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"1","key":"10.1002\/14651858.CD008550.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/j.1536-4801.2012.tb00025.x","article-title":"Esomeprazole for the treatment of GERD in infants ages 1-11 months","volume":"55","author":"Winter","year":"2012","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"6","key":"10.1002\/14651858.CD008550.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/MPG.0b013e318207834d","article-title":"Pharmacokinetics and tolerability of rabeprazole in children 1 to 11 years old with gastroesophageal reflux disease","volume":"52","author":"Zannikos","year":"2011","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"11","key":"10.1002\/14651858.CD008550.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.clinthera.2006.11.012","article-title":"Pharmacokinetic properties of esomeprazole in children aged 1 to 11 years with symptoms of gastroesophageal reflux disease: a randomized, open-label study","volume":"28","author":"Zhao","year":"2006","journal-title":"Clinical Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD008550.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jpeds.2013.05.007","article-title":"Efficacy and safety of once-daily esomeprazole for the treatment of gastroesophageal reflux disease in neonatal patients","volume":"163","author":"Davidson","year":"2013","journal-title":"Journal of Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD008550.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/MPG.0b013e3182a4e718","article-title":"Efficacy and safety of rabeprazole in children (1-11 years) with gastroesophageal reflux disease","volume":"57","author":"Haddad","year":"2013","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"4","key":"10.1002\/14651858.CD008550.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/MPG.0000000000000229","article-title":"Maintenance of efficacy and safety of rabeprazole in children with endoscopically proven GERD","volume":"58","author":"Haddad","year":"2014","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"3","key":"10.1002\/14651858.CD008550.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1365-2036.2011.04950.x","article-title":"Long-term maintenance treatment with omeprazole in children with healed erosive oesophagitis: a prospective study","volume":"35","author":"Hassall","year":"2012","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD008550.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"e299","DOI":"10.1016\/j.dld.2013.08.217","article-title":"A prospective, comparative, randomized, controlled study on the efficacy of the treatment with magnesium (Mg-) alginate in infants with gastroesophageal reflux","volume":"45","author":"Ummarino","year":"2013","journal-title":"Digestive and Liver Disease"},{"issue":"3","key":"10.1002\/14651858.CD008550.pub2-BIB0080|cit80","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002300","article-title":"Cisapride treatment for gastrooesophageal reflux in children","author":"Augood","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008550.pub2-BIB0081|cit81","volume-title":"BNF for children","author":"British Medical Association","year":"2013"},{"issue":"3","key":"10.1002\/14651858.CD008550.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1542\/peds.2007-3569","article-title":"Prevalence and natural history of gastroesophageal reflux: pediatric prospective survey","volume":"123","author":"Campanozzi","year":"2009","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD008550.pub2-BIB0083|cit83","first-page":"9","article-title":"Cisapride (Prepulsid) withdrawn","volume":"26","author":"Committee on Safety of Medicines and Medicines Control Agency","year":"2000","journal-title":"Current Problems in Pharmacovigilance"},{"issue":"3","key":"10.1002\/14651858.CD008550.pub2-BIB0084|cit84","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003502.pub3","article-title":"Metoclopramide, thickened feedings, and positioning for gastro-oesophageal reflux in children under two years (Cochrane Review)","author":"Craig","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD008550.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00128072-200002040-00003","article-title":"Role of drug therapy in the treatment of gastro-oesophageal reflux disorder in children","volume":"2","author":"Cucchiara","year":"2000 July-August","journal-title":"Paediatric Drugs"},{"key":"10.1002\/14651858.CD008550.pub2-BIB0086|cit86","unstructured":"European Medicine Agency Committee on Medicinal Products for Human Use European Medicines Agency recommends changes to the use of metoclopramide http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/news_and_events\/news\/2013\/07\/news_detail_001854.jsp&mid=WC0b01ac058004d5c1"},{"key":"10.1002\/14651858.CD008550.pub2-BIB0087|cit87","first-page":"EMA\/129231\/2014","article-title":"PRAC recommends restricting use of domperidone","author":"European Medicines Agency","year":"2012","journal-title":"European Medicines Agency"},{"key":"10.1002\/14651858.CD008550.pub2-BIB0088|cit88","unstructured":"Food Drug Administration (FDA) FDA requires boxed warning and risk mitigation strategy for metoclopramide-containing drugs [press release] Food and Drug Administration; Rockville, MD,"},{"issue":"3","key":"10.1002\/14651858.CD008550.pub2-BIB0089|cit89","first-page":"285","article-title":"Acute extrapyramidal dysfunction after domperidone administration. Report of a case","volume":"39","author":"Franckx","year":"1984","journal-title":"Helvetica Paediatrica Acta"},{"key":"10.1002\/14651858.CD008550.pub2-BIB0090|cit90","unstructured":"Reckitt Benckiser Healthcare (UK) Limited Gaviscon Product Information Reckitt Benckiser Healthcare (UK) Limited, Dansom Lane, Hull, HU8 7DS"},{"issue":"10","key":"10.1002\/14651858.CD008550.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/adc.2004.069674","article-title":"Outcomes of fundoplication: causes for concern, newer options","volume":"90","author":"Hassall","year":"2005","journal-title":"Archives of Disease in Childhood"},{"key":"10.1002\/14651858.CD008550.pub2-BIB0092|cit92","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2008"},{"issue":"4","key":"10.1002\/14651858.CD008550.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3109\/07853899908995890","article-title":"Clinical spectrum of food allergy in children in Australia and South-East Asia: identification and targets for treatment","volume":"31","author":"Hill","year":"1999","journal-title":"Annals of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD008550.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/00005176-198801000-00011","article-title":"Clinical and laboratory correlates of esophagitis","volume":"7","author":"Hyams","year":"1988","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"key":"10.1002\/14651858.CD008550.pub2-BIB0095|cit95","first-page":"1426","article-title":"Ranitidine tachyphylaxis","volume":"88","author":"Hyman","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD008550.pub2-BIB0096|cit96","first-page":"ep114","article-title":"Update on drugs for gastro-oesophageal reflux disease","volume":"92","author":"Keady","year":"2007","journal-title":"Archives of Disease in Childhood"},{"issue":"6","key":"10.1002\/14651858.CD008550.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1046\/j.1365-2036.2000.00759.x","article-title":"Review article: alginate-raft formulations in the treatment of heartburn and acid reflux","volume":"14","author":"Mandel","year":"2000 Jun","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD008550.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1542\/peds.109.6.1061","article-title":"Natural history and familial relationships of infant spilling to 9 years of age","volume":"109","author":"Martin","year":"2002","journal-title":"Pediatrics"},{"issue":"9","key":"10.1002\/14651858.CD008550.pub2-BIB0099|cit99","first-page":"http:\/\/www.mhra","article-title":"Proton pump inhibitors in long-term use: reports of hypomagnesaemia","volume":"5","author":"Medicines Health Regulatory Authority","year":"April 2012","journal-title":"Drug Safety Update"},{"issue":"9","key":"10.1002\/14651858.CD008550.pub2-BIB0100|cit100","first-page":"http:\/\/www.mhra","article-title":"Proton pump inhibitors in long-term use: recent epidemiological evidence of increased risk of fracture","volume":"5","author":"Medicines Health Regulatory Authority","year":"2012","journal-title":"Drug Safety Update"},{"issue":"4","key":"10.1002\/14651858.CD008550.pub2-BIB0101|cit101","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/MPG.0b013e3181b7f563","article-title":"Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN)","volume":"49","author":"Vandenplas","year":"2009","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"3","key":"10.1002\/14651858.CD008550.pub2-BIB0102|cit102","first-page":"93","article-title":"Does long-term inhibition of gastric acid secretion with omeprazole lead to small intestinal bacterial overgrowth?","volume":"45","author":"Nelis","year":"1994","journal-title":"Netherlands Journal of Medicine"},{"key":"10.1002\/14651858.CD008550.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/archpedi.1997.02170430035007","article-title":"Prevalence of symptoms of gastro-oesophageal reflux during infancy: a paediatric practice-based survey","volume":"151","author":"Nelson","year":"1997","journal-title":"Archives of Pediatrics and Adolescent Medicine"},{"key":"10.1002\/14651858.CD008550.pub2-BIB0104|cit104","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2011"},{"issue":"1","key":"10.1002\/14651858.CD008550.pub2-BIB0105|cit105","first-page":"95","article-title":"Oculogyric crisis due to domperidone therapy","volume":"40","author":"Shafrir","year":"1985","journal-title":"Helvetica Paediatrica Acta"},{"issue":"5","key":"10.1002\/14651858.CD008550.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/ajg.2009.129","article-title":"A global, evidence-based consensus on the definition of gastroesophageal reflux disease in the pediatric population","volume":"104","author":"Sherman","year":"2009","journal-title":"American Journal of Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD008550.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3748\/wjg.v5.i5.375","article-title":"Diagnosis and treatment of gastroesophageal reflux disease in infants and children","volume":"5","author":"Vandenplas","year":"1999 Oct","journal-title":"World Journal of Gastroenterology"}],"updated-by":[{"DOI":"10.1002\/14651858.cd008550.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD008550.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T08:48:42Z","timestamp":1717577322000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD008550.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Upper GI and Pancreatic Diseases Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,11,24]]},"references-count":107,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2016,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008550.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD008550.pub3","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,24]]}}}